BioCryst Pharmaceuticals Inc (NAS:BCRX)
$ 7.82 -0.37 (-4.52%) Market Cap: 1.62 Bil Enterprise Value: 2.18 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 75/100

BioCryst Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 28, 2021 / 06:00PM GMT
Release Date Price: $14.73 (-4.23%)
Lut Ming Cheng
Cantor Fitzgerald & Co., Research Division - Research Analyst

Good afternoon. Thank you for joining us at our annual health care conference. I'm Brian Cheng. I'm the senior biotech analyst here at Cantor.

Joining us today is the full team, management team from BioCryst. With us, we have Jon Stonehouse, President and CEO; Anthony Doyle; Charlie; Bill; John; and Helen.

So maybe Jon to get us started, let's talk about your story and also the pipeline that you're working on. Can you just spend a few minutes to give us a quick highlight of your company and the work that you're doing so far? And then we'll jump right back into a Q&A.

Jon P. Stonehouse
BioCryst Pharmaceuticals, Inc. - CEO, President & Executive Director

Sure. Absolutely. Brian, first, thanks for inviting us to the Cantor conference. It's fantastic to have you as an analyst. We've known Brian for a while, all the way back to another bank that I won't name the name. But you've always been known for doing extremely thorough work. And his recent survey, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot